Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy

被引:24
作者
Wang, Shiyang [1 ]
Shi, Yue [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Geriatr Surg, Shenyang 110001, Peoples R China
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2022年 / 17卷
关键词
tumor; exosome; tumor immunity; immune cells; engineered exosomes; NATURAL-KILLER-CELLS; CD4(+) T-CELLS; DENDRITIC CELLS; EXTRACELLULAR VESICLES; PROMOTES PROLIFERATION; LOADED EXOSOMES; B-CELLS; CANCER; PACLITAXEL; RESPONSES;
D O I
10.2147/IJN.S388604
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Exosomes are small vesicles secreted by living cells, with a typical lipid bilayer structure. They carry a variety of proteins, lipids, RNA and other important information, play an important role in the transmission of substances and information between cells, and gradually become a marker for early diagnosis of many diseases and an important tool in drug delivery system. Immune cells are an important part of tumor microenvironment, and they can affect tumor progression by secreting a variety of immunoreactive substances. This review focuses on the effects of various immune cell-derived exosomes on tumor cells, different immune cells and other stromal cells in tumor microenvironment. Exosomes derived from different immune cells can not only reshape a pro-inflammatory microenvironment to inhibit tumor progression, but also promote tumor progression by inhibiting the killing effect of NK cells, CD8+T cells and other cells or promoting tumor cells and immunosuppressive immune cells. In addition, we also discussed that some exosomes derived from immune cells (such as DC, M1 macrophages and neutrophils) play a tumor inhibitory role after being engineered.
引用
收藏
页码:6527 / 6550
页数:24
相关论文
共 158 条
  • [1] Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival
    Aiello, Sistiana
    Rocchetta, Federica
    Longaretti, Lorena
    Faravelli, Silvia
    Todeschini, Marta
    Cassis, Linda
    Pezzuto, Francesca
    Tomasoni, Susanna
    Azzollini, Nadia
    Mister, Marilena
    Mele, Caterina
    Conti, Sara
    Breno, Matteo
    Remuzzi, Giuseppe
    Noris, Marina
    Benigni, Ariela
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [2] Macrophage-Based Approaches for Cancer Immunotherapy
    Anderson, Nicholas R.
    Minutolo, Nicholas G.
    Gill, Saar
    Klichinsky, Michael
    [J]. CANCER RESEARCH, 2021, 81 (05) : 1201 - 1208
  • [3] Advanced drug delivery 2020 and beyond: Perspectives on the future
    Bae, You Han
    Park, Kinam
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2020, 158 : 4 - 16
  • [4] Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
    Bagchi, Sreya
    Yuan, Robert
    Engleman, Edgar G.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021, 2021, 16 : 223 - 249
  • [5] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [6] Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
    Besse, Benjamin
    Charrier, Melinda
    Lapierre, Valerie
    Dansin, Eric
    Lantz, Olivier
    Planchard, David
    Le Chevalier, Thierry
    Livartoski, Alain
    Barlesik, Fabrice
    Laplanche, Agnes
    Ploix, Stephanie
    Vimond, Nadege
    Peguillet, Isabelle
    Thery, Clotilde
    Lacroix, Ludovic
    Zoernig, Inka
    Dhodapkar, Kavita
    Dhodapkar, Madhav
    Viaud, Sophie
    Soria, Jean-Charles
    Reiners, Katrin S.
    von Strandmann, Elke Pogge
    Vely, Frederic
    Rusakiewicz, Sylvie
    Eggermont, Alexander
    Pitt, Jonathan M.
    Zitvogel, Laurence
    Chaput, Nathalie
    [J]. ONCOIMMUNOLOGY, 2016, 5 (04):
  • [7] Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma
    Binenbaum, Yoav
    Fridman, Eran
    Yaari, Zvi
    Milman, Neta
    Schroeder, Avi
    Ben David, Gil
    Shlomi, Tomer
    Gil, Ziv
    [J]. CANCER RESEARCH, 2018, 78 (18) : 5287 - 5299
  • [8] CD4+ T cell help in cancer immunology and immunotherapy
    Borst, Jannie
    Ahrends, Tomasz
    Babala, Nikolina
    Melief, Cornelis J. M.
    Kastenmueller, Wolfgang
    [J]. NATURE REVIEWS IMMUNOLOGY, 2018, 18 (10) : 635 - 647
  • [9] Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
    Bronte, Vincenzo
    Brandau, Sven
    Chen, Shu-Hsia
    Colombo, Mario P.
    Frey, Alan B.
    Greten, Tim F.
    Mandruzzato, Susanna
    Murray, Peter J.
    Ochoa, Augusto
    Ostrand-Rosenberg, Suzanne
    Rodriguez, Paulo C.
    Sica, Antonio
    Umansky, Viktor
    Vonderheide, Robert H.
    Gabrilovich, Dmitry I.
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [10] Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway
    Cai, Zhijian
    Yang, Fei
    Yu, Lei
    Yu, Zhou
    Jiang, Lingling
    Wang, Qingqing
    Yang, Yunshan
    Wang, Lie
    Cao, Xuetao
    Wang, Jianli
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188 (12) : 5954 - 5961